KEY FEATURES
| Full Name | Glutathione S Transferase Mu 3, Brain |
|---|---|
| Synonym | GST-M3; GST5; GSTB; GSTM3-3; GTM3 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human GSTm3 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GSTm3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human GSTm3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human GSTm3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human GSTm3. You can calculate the concentration of Human GSTm3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human GSTm3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.01 | 2.76 | 9.52 | 1.03 | 2.96 | 9.59 |
| Standard deviation | 0.06 | 0.11 | 0.32 | 0.07 | 0.16 | 0.5 |
| CV(%) | 6.04 | 4.09 | 3.38 | 6.88 | 5.31 | 5.2 |
RECOVERY
The recovery of Human GSTm3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 87-103 | 94 |
| EDTA plasma (n=8) | 94-106 | 100 |
| Cell culture media (n=8) | 85-97 | 90 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human GSTm3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GSTM3 ELISA Kits
| CYP1A1 ELISA Kit | publications with GSTM3 and CYP1A1 |
| GSTM2 ELISA Kit | publications with GSTM3 and GSTM2 |
| CYP1B1 ELISA Kit | publications with GSTM3 and CYP1B1 |
| CYP2E1 ELISA Kit | publications with GSTM3 and CYP2E1 |
| EPHX1 ELISA Kit | publications with GSTM3 and EPHX1 |
| GSTO1 ELISA Kit | publications with GSTM3 and GSTO1 |
| CYP2C19 ELISA Kit | publications with GSTM3 and CYP2C19 |
| GSTZ1 ELISA Kit | publications with GSTM3 and GSTZ1 |
Pathways associated with GSTM3 ELISA Kit
| Biological Oxidations Pathway | Biological Oxidations Pathway |
| Chemical Carcinogenesis Pathway | Chemical Carcinogenesis Pathway |
| Defective AHCY Causes Hypermethioninemia With S-adenosylhomocysteine Hydrolase Deficiency (HMAHCHD) Pathway | Defective AHCY Causes Hypermethioninemia With S-adenosylhomocysteine Hydrolase Deficiency (HMAHCHD) Pathway |
| Defective GCLC Causes Hemolytic Anemia Due To Gamma-glutamylcysteine Synthetase Deficiency (HAGGSD) Pathway | Defective GCLC Causes Hemolytic Anemia Due To Gamma-glutamylcysteine Synthetase Deficiency (HAGGSD) Pathway |
| Defective GGT1 Causes Glutathionuria (GLUTH) Pathway | Defective GGT1 Causes Glutathionuria (GLUTH) Pathway |
| Defective GSS Causes Glutathione Synthetase Deficiency (GSS Deficiency) Pathway | Defective GSS Causes Glutathione Synthetase Deficiency (GSS Deficiency) Pathway |
| Defective MAT1A Causes Methionine Adenosyltransferase Deficiency (MATD) Pathway | Defective MAT1A Causes Methionine Adenosyltransferase Deficiency (MATD) Pathway |
| Defective OPLAH Causes 5-oxoprolinase Deficiency (OPLAHD) Pathway | Defective OPLAH Causes 5-oxoprolinase Deficiency (OPLAHD) Pathway |
| Defective SLC35D1 Causes Schneckenbecken Dysplasia (SCHBCKD) Pathway | Defective SLC35D1 Causes Schneckenbecken Dysplasia (SCHBCKD) Pathway |
Diseases associated with GSTM3 ELISA Kit
| Lung Neoplasms | publications with GSTM3 and Lung Neoplasms |
| Liver Diseases | publications with GSTM3 and Liver Diseases |
| Nervous System Diseases | publications with GSTM3 and Nervous System Diseases |
| Liver Neoplasms | publications with GSTM3 and Liver Neoplasms |
| Colorectal Neoplasms | publications with GSTM3 and Colorectal Neoplasms |
| Carcinoma, Hepatocellular | publications with GSTM3 and Carcinoma, Hepatocellular |
| Necrosis | publications with GSTM3 and Necrosis |
| Breast Neoplasms | publications with GSTM3 and Breast Neoplasms |
| Disease Models, Animal | publications with GSTM3 and Disease Models, Animal |
| Neoplasms, Experimental | publications with GSTM3 and Neoplasms, Experimental |
Organs/Tissues associated with GSTM3 ELISA Kit
| Lung | publications with GSTM3 and Lung |
| Blood | publications with GSTM3 and Blood |
| Liver | publications with GSTM3 and Liver |
| Brain | publications with GSTM3 and Brain |
| Skin | publications with GSTM3 and Skin |
| Kidney | publications with GSTM3 and Kidney |
| Mouth | publications with GSTM3 and Mouth |
| Bladder | publications with GSTM3 and Bladder |
| Eye | publications with GSTM3 and Eye |
| Testis | publications with GSTM3 and Testis |